Aarti Pharmalabs Limited (AARTIPHARM)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 374.27 358.14 356.14 373.03 414.82 393.49 377.29 470.95 529.62 375.31 417.29 425.25
YOY Revenue Growth % - - - - 10.83% 9.87% 5.94% 26.25% 27.68% -4.62% 10.6% -9.7%
Other Income 0.00 4.86 0.00 0.20 5.69 2.11 2.95 11.94 -2.51 1.60 3.15 -0.37
Total Income 374.27 363.00 356.14 373.23 420.50 395.60 380.24 482.88 527.12 376.91 420.44 424.88
Total Expenses + 306.17 286.68 288.45 290.08 300.12 298.09 309.08 362.67 413.62 309.73 378.74 363.51
Cost of Materials Consumed 210.12 193.64 196.88 191.11 179.69 191.41 196.38 242.91 173.29 192.85 204.45 209.85
Employee Benefit Expense 30.94 31.53 29.84 34.29 34.67 37.01 35.47 39.02 41.38 41.01 43.12 42.62
Other Expenses 65.11 61.51 61.73 64.68 85.75 69.67 77.23 80.75 85.02 79.41 90.19 108.25
Operating Profit 68.10 71.46 67.69 82.95 114.70 95.40 68.22 108.28 116.01 65.58 38.55 61.75
OPM % 18.2% 20% 19% 22.2% 27.7% 24.2% 18.1% 23% 21.9% 17.5% 9.2% 14.5%
Profit Before Tax + 56.74 62.13 53.66 67.44 91.28 63.23 63.43 96.18 113.50 67.17 41.70 58.58
Tax Expense 16.75 14.50 12.48 19.25 28.26 16.08 15.60 22.66 24.66 15.95 10.77 14.74
Tax % 29.5% 23.3% 23.3% 28.5% 31% 25.4% 24.6% 23.6% 21.7% 23.7% 25.8% 25.2%
Profit After Tax 39.99 47.63 41.18 48.19 63.02 47.14 47.84 73.52 88.85 51.22 30.93 43.84
EPS (Basic) 4.41 5.26 4.61 5.32 6.95 5.20 5.28 8.11 9.80 5.65 3.41 4.84

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 1,771.35 1,502.13 1,511.25
YOY Revenue Growth % 17.92% -0.6% -
Other Income 14.49 11.01 1.28
Total Income 1,785.84 1,513.14 1,512.53
Total Expenses + 1,449.50 1,165.57 1,284.44
Cost of Materials Consumed 803.98 761.57 899.45
Employee Benefit Expense 152.88 130.33 122.16
Other Expenses 312.66 273.67 262.83
Operating Profit 321.85 336.56 226.81
OPM % 18.2% 22.4% 15%
Profit Before Exceptional 336.34 274.52 233.36
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 336.34 274.52 233.36
Tax Expense 78.99 73.87 61.63
Tax % 23.5% 26.9% 26.4%
Profit After Tax 257.35 200.65 171.73
EPS (Basic) 28.39 22.14 18.95

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 1,510.81 1,162.85 1,004.30
Property, Plant & Equipment 1,028.77 936.47 847.08
Capital Work in Progress 300.92 78.50 62.23
Non-Current Investments 41.15 43.83 42.68
Goodwill 0.00 0.00 0.00
Other Intangible Assets 30.55 16.86 1.32
Current Assets + 1,212.80 1,134.06 958.97
Inventories 544.22 582.15 537.68
Trade Receivables 552.59 448.82 361.61
Cash and Cash Equivalents 2.84 4.00 13.11
Current Investments 15.88 17.83 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 45.32 45.31 45.31
Other Equity 1,798.55 1,576.15 1,393.27
Non-Current Liabilities 257.40 119.87 69.38
Current Liabilities 622.33 555.58 455.31
Total Liabilities 879.74 675.45 524.69

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 340.01 183.70 228.69
Cash from Investing Activities -419.80 -184.40 -115.56
Cash from Financing Activities 78.63 4.40 -156.52
Net Increase/Decrease in Cash -1.16 3.70 -43.39